Literature DB >> 25498051

Serum microRNAs as new diagnostic biomarkers for pre- and post-kidney transplantation.

W Sui1, M Yang1, F Li1, H Chen1, J Chen1, M Ou1, Y Zhang1, H Lin1, W Xue1, Y Dai2.   

Abstract

BACKGROUND: In the present study, we compared the expression levels of 3 microRNAs (miRNAs) between patients who had undergone kidney transplantation and healthy individuals in a search for a new diagnostic biomarker after kidney transplantation.
METHODS: We used real-time quantitative polymerase chain reaction to investigate the expression levels of miR-181a, miR-483-5p, and miR-557 in the serum of 15 kidney transplantation patients before transplantation on the first, third, and seventh days after transplantation. The study was performed in the Guilin 181st Hospital between 2010 and 2012. The results of this study may assist with early diagnosis and treatment and contribute to our understanding of the pathological parameters. Receiver operating characteristic (ROC) analysis was performed to determine the area under the curve of each equation to predict evolution to rejection.
RESULTS: ROC curves were performed to explore miRNAs to predict rejection occurrence after transplantation showed pre-transplantation expression levels of miR-181a to be a potential factor with a significant area under the curve (AUC = 0.985, P < .05). The expression of miR-181a before kidney transplantation was also significantly different on days 1 and 3 after kidney transplantation, the area under the curve (AUC) was, respectively, 0.980 (P < .05) and 0.830 (P < .05). Predictors on days 1, 3, and 7 show that miR-483-5p and miR-557 are also predictive factors for rejection. Predictors for miR-483-5p and miR-557 were significantly under the area ROC, respectively (AUC = 0.920, P < .05), and (AUC = 0.990, P < .005) on day 1 (AUC = 0.920, P < .05) and (AUC = 0.960, P < .005) on day 3, (AUC = 0.845, P < .05) and (AUC = 0.889, P < .05) on day 7.
CONCLUSIONS: This study of miRNAs was unrelated to age, sex, histological classification, and metastasis (all P > .05). Serum miR-181a, miR-483-5p, and miR-557 could serve as circulating biomarkers for the early diagnosis of active situations of before and after kidney transplantation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25498051     DOI: 10.1016/j.transproceed.2014.08.050

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.

Authors:  Olga Millán; Klemens Budde; Claudia Sommerer; Irene Aliart; Olesja Rissling; Beatriz Bardaji; Maaren Matz; Martin Zeier; Irene Silva; Lluis Guirado; Mercè Brunet
Journal:  Br J Clin Pharmacol       Date:  2017-09-21       Impact factor: 4.335

2.  [A method for efficient transduction of miR-483-5p in the kidney of mice].

Authors:  Ying Xia; Xue-Juan Zhou; Wen-Qing Gu; Yan-Yan Zhao; Xiao Xiao; Xiao-Chun Bai; Jun Liu; Ming Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

3.  MicroRNA-483-5p accentuates cisplatin-induced acute kidney injury by targeting GPX3.

Authors:  Ying Xia; Wenbin Pan; Xiao Xiao; Xuejuan Zhou; Wenqing Gu; Yaqin Liu; Yanyan Zhao; Lixia Li; Chenghao Zheng; Jun Liu; Ming Li
Journal:  Lab Invest       Date:  2022-02-18       Impact factor: 5.662

4.  The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.

Authors:  Yan Wang; Yujie Guo; Xiaolei Zhang; Hui Zhao; Bingbing Zhang; Yi Wu; Jingyu Zhang
Journal:  RNA Biol       Date:  2021-02-15       Impact factor: 4.652

5.  Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease.

Authors:  Rimpi Khurana; Glory Ranches; Simon Schafferer; Melanie Lukasser; Michael Rudnicki; Gert Mayer; Alexander Hüttenhofer
Journal:  RNA       Date:  2016-11-21       Impact factor: 4.942

6.  Circulating miRNAs as biomarkers of kidney disease.

Authors:  Alexander Hüttenhofer; Gert Mayer
Journal:  Clin Kidney J       Date:  2016-08-23

Review 7.  Biomarkers in renal transplantation: An updated review.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  World J Transplant       Date:  2017-06-24

8.  Identification of a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for chronic kidney disease using next-generation sequencing.

Authors:  Xinying Liu; Weijie Wang; Yaling Bai; Huiran Zhang; Shenglei Zhang; Lei He; Wei Zhou; Dongxue Zhang; Jinsheng Xu
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.